SCHEMBL2717044

SCHEMBL2717044

CC(C)(C)[S+]([O-])NCCc1nc2ccc(F)cc2cc1-c1cccc(S(C)(=O)=O)n1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2717042 1.00 MAPK14 (0.31) MAPK14
SCHEMBL2717351 0.80 IDO1 (0.34) MAPK14
SCHEMBL2718966 0.80
SCHEMBL2718963 0.80
SCHEMBL3777197 0.79 PIK3CD (0.39) MAPK14
SCHEMBL2717040 0.79 PIK3CD (0.39) MAPK14
SCHEMBL2717752 0.77 KCNA5 (0.33) MAPK14
SCHEMBL19787839 0.75 SCD (0.31)
SCHEMBL2720253 0.74 PIK3CD (0.49)
SCHEMBL2718211 0.74 PIK3CG (0.33) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2445900-A2 POLYCYCLIC DERIVATIVES OF PYRIDINE AND THEIR USE IN THE TREATMENT OF (INTER ALIA) RHEUMATOID ARTHRITIS AND SIMILAR DISEASES Amgen, Inc (US) 2012-05-02 EP disclosed
WO-2010151740-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2010-12-29 WO disclosed